Fremdkapital Veränderung Datum
Adma Biologics USD 191.64M 1.2M 2026-09
Alnylam Pharmaceuticals USD 2.11B 358.58M 2026-09
BioMarin Pharmaceutical USD 3.51B 12.96M 2026-09
Cytokinetics USD 244.33M 3.87M 2026-09
Gilead Sciences USD 23.82B 17M 2026-09
Heron Therapeutics USD 140.64M 975K 2025-12
Immunic USD 0 0 2024-06
Insmed USD 544.86M 1.35M 2026-09
Knight Therapeutics CAD 57.78M 26.92M 2025-12
MacroGenics USD 163.16M 94.44M 2026-06
Omeros USD 403.72M 27.2M 2024-06
Pfizer USD 60B 498M 2026-09
Rockwell Medical USD 8.65M 89K 2025-06
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 699.39M 148.23M 2026-09
United Therapeutics USD 100M 100M 2024-06
Vertex Pharmaceuticals USD 3.5B 3.39B 2026-09